Insulet has been granted a patent for a wearable automated medication delivery system. The system includes a sensor to collect user information, an electronic device to transmit data, a wearable medical device with a medication reservoir and controller, and an attachable module for communication. The system can wirelessly communicate with the sensor and electronic device, and receive glucose levels directly from the sensor. GlobalData’s report on Insulet gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Insulet, Wearable drug delivery devices was a key innovation area identified from patents. Insulet's grant share as of September 2023 was 46%. Grant share is based on the ratio of number of grants to total number of patents.
Wearable automated medication delivery system with wireless communication
A recently granted patent (Publication Number: US11744944B2) describes a wearable automated medication delivery system. The system includes a sensor that is attached to the user and measures a physical attribute of the user, such as glucose levels. The sensor wirelessly transmits this data to an electronic device, which can communicate with a cloud-based server.
The wearable medical device in the system is adhered to the user using a pad and includes a reservoir for medication and a controller. An attachable module with a transceiver and wired connection can be removably attached to the wearable medical device and communicate with the controller. The transceiver is capable of wirelessly communicating with the sensor and electronic device, as well as receiving glucose levels directly from the sensor.
The patent also mentions that the sensor and wearable medical device can be attached to different locations on the user's body. Additionally, a wearable wireless accessory device with a user input device is included in the system. This device can present the determined medication bolus size and receive confirmation input from the user.
The controller in the wearable medical device is responsible for wireless transmission of the user's glucose levels and the determined medication bolus size to the cloud-based server and/or the electronic device. The electronic device mentioned in the patent is specifically referred to as a cellphone.
The patent also describes a wireless device that enables wireless communication by the wearable medical device. This wireless device includes a transceiver for wireless communication, a wired connection to the controller of the wearable medical device, and can be removably attached to the wearable medical device. It can transmit instructions to deliver medication to the user to a wearable wireless accessory device and receive notifications from the controller indicating the delivery of medication. The wireless device can also receive data of the user's physical attribute level from a sensor and provide it to the controller. Additionally, it can transmit a confirmation message indicating that the wearable drug delivery device has delivered the medication to the user.
Overall, this patent describes a wearable automated medication delivery system that utilizes sensors, wireless communication, and a cloud-based server to monitor and deliver medication to users. The system aims to improve medication management and adherence for individuals.
To know more about GlobalData’s detailed insights on Insulet, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
